Outsourced Pharma White Papers

  1. Accelerating An Innovative High Potency Oncology Therapy To Market 5/13/2026

    Learn how disciplined containment, proactive risk management, and collaboration accelerate complex oncology programs under tight timelines while protecting quality, safety, and global launch readiness.

  2. USP <665> Becomes Official On May 1, 2026. Are You Ready? 2/24/2026

    With USP <665> becoming official on May 1, 2026, proactive preparation is essential to ensure compliance and prevent delays, regulatory observations, or supply chain disruptions.

  3. A Shift Towards Biofluorescent Particle Counters In Manufacturing 5/12/2025

    Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

  4. Continuous Manufacturing For API Breakthroughs 3/17/2026

    Observe how a compound library, designed for chemical diversity and lead-like properties, uses advanced filtering to improve hit discovery, speed hit-to-lead development, and boost early-stage small molecule drug discovery.

  5. Quality By Design: The Importance Of Reference Standards In Drug Development 8/1/2024

    Learn more about the comprehensive lifecycle management of reference standards, encompassing qualification, characterization, and storage procedures.

  6. Digital Standardization: Accelerating Gene Therapy Tech Transfer With Confidence And Compliance 4/1/2026

    Fragmented, manual data practices slow tech transfer and increase risk; centralized digital CMC systems standardize workflows, improve transparency, and accelerate onboarding while maintaining compliance.

  7. Advancing Nanomedicine Production With Flow Manufacturing 5/6/2026

    Learn how flow manufacturing enables scalable, reproducible nanomedicine production with tighter control, consistent particle quality, and smooth lab-to-commercial scale‑up.

  8. The Relevance Of Polymorph Screening In The Pharmaceutical Industry 3/31/2025

    Polymorph screening identifies different solid forms of active pharmaceutical ingredients, optimizing drug stability, solubility, and manufacturability. This process ensures quality, regulatory compliance, and intellectual property protection in pharmaceutical development.

  9. Advancements In Microbial Manufacturing Of Biopharmaceuticals 9/26/2024

    Dive into the evolution and future potential of microbial manufacturing in the biopharmaceutical industry to discover how digital tools can revolutionize development and production processes.

  10. 5 Steps To Design A Microbiological Performance Qualification For Facilities 4/21/2025

    Explore five steps to design an EMPQ for sterile manufacturing: classification, protocol drafting, cleaning evaluation, disinfectant efficacy testing, and continuous improvement.